Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial
Paper published in the BMJ.
Read more
Welcome to Oxford Trauma and Emergency Care
Trauma and emergencies are huge issues for patients, the NHS and society more broadly. Oxford Trauma and Emergency Care seeks to improve patient care by designing and testing new treatments and new treatment pathways. We aim to deliver better outcomes for patients and more efficient care within the NHS and other healthcare system worldwide.
We run a number of clinical trials and related studies in trauma and emergency care to guide best practice in the field. Our work informs practice and policy in the NHS and internationally through bodies such as the National Institute for Health and Care Excellence (NICE) guidelines.
Oxford Trauma and Emergency Care is based in the Kadoorie Centre located at the John Radcliffe Hospital, but has collaborations across the University and outside.
Our research focuses on the clinical and cost effectiveness of orthopaedic surgery.
NOVEMBER 2023 TRIAL STATS
Patients recruited
181
New sites
Horton General Hospital,
University of Wales Hospital,
Basingstoke and North Hampshire Hospital,
Southampton General Hospital
Sites with the most recruits in November
Minton Keynes University Hospital - 28
Addenbrookes - 7
Work with us
-
Associate Professor of Orthopaedic Trauma Surgery (169198)
Closing date: 11 December 2023
Applications are invited for an Associate Professorship of Orthopaedic Trauma Surgery, a joint appointment with a non-tutorial Fellowship at Wolfson College.
TEAM
RESEARCH
EVENTS
Latest news
The Big BOSS Study Opens to Recruitment!
3 November 2023
Antibiotic bone cement found not to reduce infection after hip replacement
22 June 2023
A large trial has found that using high-dose dual-antibiotic loaded cement is unlikely to reduce the risk of surgical site infection in people who have had a hip replacement.
Kadoorie research paper receives EFORT gold award
19 June 2023
A paper for the PATH-2 trial has received a gold award from the European Federation of National Associations of Orthopaedics and Traumatology (EFORT).
MAIN FUNDER
